| Nimotuzumab studied in …STUDIED_INderived109 of 109show fewer |
|---|
| → studied in | NCT07821242Phase 2 · not yet recruiting Nimotuzumab Plus Radiotherapy in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07736612Phase 1/Phase 2 · not yet recruiting A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer · 109 trials list this drug (32 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07706985Phase 3 · recruiting Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal Carcinoma · 109 trials list this drug (32 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07707973Phase 2 · not yet recruiting Nimotuzumab Combined With the Stupp Regimen for Postoperative Residual Glioblastoma · 109 trials list this drug (32 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07601737Phase 2 · recruiting Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Head and Neck Neoplasm,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06770452Phase 2 · recruiting HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients · 109 trials list this drug (32 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07535567Phase 2/Phase 3 · not yet recruiting Postoperative Radiotherapy With Nimotuzumab ± Benmelstobart in Intermediate-Risk Head and Neck Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07445048Phase 3 · recruiting Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07457528Phase 2 · recruiting Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC · 109 trials list this drug (32 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04821778Phase 3 · recruiting Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04821843Phase 3 · recruiting Neoadjuvant Treatment Modalities in Esophageal Cancer · 109 trials list this drug (32 active) | — | — | Esophageal Neoplasm,Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07353723Phase 2 · recruiting Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07333274Phase 3 · recruiting Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07312578Phase 2 · enrolling by invitation Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277452Phase 2 · not yet recruiting Nimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic Cancer · 109 trials list this drug (32 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06509009Phase 2 · recruiting Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma · 109 trials list this drug (32 active) | — | — | Nasopharyngeal Carcinoma by AJCC v8 Stage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07070479Phase 2 · recruiting Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial · 109 trials list this drug (32 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06048913Phase 2 · completed Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age · 109 trials list this drug (32 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06988956Phase 2 · recruiting Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06912711Phase 2 · recruiting TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma · 109 trials list this drug (32 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06938503Phase 2 · not yet recruiting AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer · 109 trials list this drug (32 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01249352Phase 2/Phase 3 · completed A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer · 109 trials list this drug (32 active) | — | — | Adenocarcinoma,Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01345084Phase 3 · withdrawn Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab · 109 trials list this drug (32 active) | — | — | Carcinoma,Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06879691Phase 4 · active not recruiting A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05278728Phase 1/Phase 2 · completed Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer · 109 trials list this drug (32 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06781073Phase 3 · completed Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma · 109 trials list this drug (32 active) | — | — | Cervical Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06771596Phase 2 · active not recruiting Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix · 109 trials list this drug (32 active) | — | — | Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02428764Phase 2 · withdrawn Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma · 109 trials list this drug (32 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06722911Phase 2 · recruiting Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06718205Phase 2 · recruiting Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06389760Phase 2 · recruiting Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer · 109 trials list this drug (32 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06422156Phase 2 · unknown SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer · 109 trials list this drug (32 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04207918Phase 2 · completed A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer · 109 trials list this drug (32 active) | — | — | Malignant Neoplasm,Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06413017Phase 2 · unknown Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06409429Phase 2/Phase 3 · not yet recruiting Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer · 109 trials list this drug (32 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06404840Phase 2 · unknown Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study · 109 trials list this drug (32 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06405685Phase 2 · unknown Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis · 109 trials list this drug (32 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03025958Phase 2 · completed Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma · 109 trials list this drug (32 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06363084completed A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer · 109 trials list this drug (32 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02395016Phase 3 · completed A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer · 109 trials list this drug (32 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06343116Phase 3 · not yet recruiting Nimotuzumab Combined With Trifluridine/Tipiracil in the Treatment of Refractory Metastatic Colorectal Cancer · 109 trials list this drug (32 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06333821Phase 3 · not yet recruiting A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma · 109 trials list this drug (32 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00957086Phase 3 · unknown Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer · 109 trials list this drug (32 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03620032Phase 2 · unknown Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses · 109 trials list this drug (32 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02947386Phase 1 · completed Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer · 109 trials list this drug (32 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06022276NA · unknown Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors · 109 trials list this drug (32 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04949503completed A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN · 109 trials list this drug (32 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05772208Phase 3 · recruiting Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy · 109 trials list this drug (32 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00702481Phase 2 · completed Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer · 109 trials list this drug (32 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05717790NA · recruiting Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma · 109 trials list this drug (32 active) | — | — | Nasopharyngeal Carcinoma by AJCC v8 Stage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03574402Phase 2 · unknown Phase II Umbrella Study Directed by Next Generation Sequencing · 109 trials list this drug (32 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03837808Phase 3 · unknown Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma · 109 trials list this drug (32 active) | — | — | Head and Neck Neoplasm,Nasopharyngeal Neoplasm,Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04475016Phase 2 · completed TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer · 109 trials list this drug (32 active) | — | — | Malignant Penile Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05316480Phase 2 · not yet recruiting Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms · 109 trials list this drug (32 active) | — | — | Pancreatic Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02591784Phase 2 · completed Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04367909Phase 2 · unknown A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024019Phase 2 · unknown Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery · 109 trials list this drug (32 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03413579Phase 3 · completed Evaluate Efficacy of the Association Nimotuzumab(HR3) /Cisplatin-Vinorelbine on Patients With Cervical Carcinom · 109 trials list this drug (32 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04976478not yet recruiting Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Cervical Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04882462Phase 2 · unknown Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC. · 109 trials list this drug (32 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04833205Phase 2 · unknown Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer · 109 trials list this drug (32 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02272699Phase 2/Phase 3 · withdrawn Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02577341Phase 2 · completed Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer · 109 trials list this drug (32 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01463605Phase 2 · completed Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial · 109 trials list this drug (32 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03915132Phase 2 · unknown Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma · 109 trials list this drug (32 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04678791NA · unknown Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Cervical Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02858206Phase 2 · unknown Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma · 109 trials list this drug (32 active) | — | — | Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03557112Phase 2 · unknown By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC · 109 trials list this drug (32 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02672241Phase 2 · unknown Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children · 109 trials list this drug (32 active) | — | — | Childhood Brain Stem Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03666221Phase 2 · unknown Nimotuzumab for Recurrent Nasopharyngeal Carcinoma · 109 trials list this drug (32 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03469531Phase 2 · unknown Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer · 109 trials list this drug (32 active) | — | — | Neoplasm,Cervical Adenosquamous Carcinoma,Cervical Squamous Intraepithelial Neoplasia 3+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03554889Phase 1 · unknown Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells · 109 trials list this drug (32 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01813253Phase 3 · terminated Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer · 109 trials list this drug (32 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03400592Phase 2 · unknown Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma · 109 trials list this drug (32 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03388372Phase 2 · completed Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma · 109 trials list this drug (32 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02409186Phase 3 · unknown A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02705612Phase 2 · unknown Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer · 109 trials list this drug (32 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02611700Phase 3 · unknown Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01074021Phase 3 · unknown Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer · 109 trials list this drug (32 active) | — | — | Malignant Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00561990Phase 2/Phase 3 · completed Nimotuzumab in Adults With Pancreatic Cancer · 109 trials list this drug (32 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02549261NA · unknown Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer · 109 trials list this drug (32 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01232374Phase 2 · unknown Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma · 109 trials list this drug (32 active) | — | — | Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00950417Phase 1 · completed Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02039791Phase 2 · unknown Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer · 109 trials list this drug (32 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293356Phase 4 · unknown Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma · 109 trials list this drug (32 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02395068Phase 1 · unknown Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors · 109 trials list this drug (32 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01145170Phase 2 · completed Nimotuzumab and Radiotherapy in Pediatric Patients With Glioma · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01939054Phase 2 · unknown Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients · 109 trials list this drug (32 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02095119Phase 1/Phase 2 · completed A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02034968Phase 2 · withdrawn Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma · 109 trials list this drug (32 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02041819Phase 2 · withdrawn Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus · 109 trials list this drug (32 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02370849Phase 2 · completed Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma · 109 trials list this drug (32 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02011594Phase 2 · withdrawn Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal Carcinoma · 109 trials list this drug (32 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01301612Phase 2 · withdrawn Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS) · 109 trials list this drug (32 active) | — | — | Carcinoma,Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01993784Phase 1/Phase 2 · unknown Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma. · 109 trials list this drug (32 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01180166Phase 2 · unknown Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer · 109 trials list this drug (32 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01899118Phase 2 · unknown Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer · 109 trials list this drug (32 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00561691completed Nimotuzumab in Children With Intrinsic Pontine Glioma · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01382745Phase 2 · terminated Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00753246Phase 3 · completed Nimotuzumab in Adults With Glioblastoma Multiforma · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01516996Phase 2 · unknown Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer · 109 trials list this drug (32 active) | — | — | Malignant Hypopharyngeal Neoplasm,Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00910117Phase 2 · completed Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) · 109 trials list this drug (32 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01402180Phase 2/Phase 3 · unknown Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy · 109 trials list this drug (32 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00600054Phase 2 · completed Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma · 109 trials list this drug (32 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369447Phase 1/Phase 2 · terminated A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer · 109 trials list this drug (32 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00872482Phase 2 · terminated A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases · 109 trials list this drug (32 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01336049Phase 2 · unknown Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer · 109 trials list this drug (32 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00493857Phase 2 · terminated Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer · 109 trials list this drug (32 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369252Phase 1 · completed Phase I Study of Nimotuzumab in Solid Tumours · 109 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |